Publications (15)

¹ Publications considered as the group’s output.

filter_list

2026

  1. Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer

    Gene Therapy

2025

  1. Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease

    Brain, Behavior, and Immunity, Vol. 128, pp. 600-611

  2. Deep Learning Models that Integrate Transcriptomic and Spatial Information, Allow Efficient Reconstruction and Clonal TCR Analysis of the Tumor Microenvironment

    Proceedings - 2025 IEEE 25th International Conference on Bioinformatics and Bioengineering, BIBE 2025

  3. Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice

    Hepatology, Vol. 82, Núm. 2, pp. 326-343

  4. Immunocytokines based on IL-12 for cancer therapy: Enhancing efficacy and reducing toxicity

    International Review of Cell and Molecular Biology (Elsevier Inc.)

  5. Inhibition of T cell infiltration and soluble TNF signaling is neuroprotective in the alpha-synuclein overexpressing mouse model of Parkinson’s disease

    npj Parkinson's Disease, Vol. 11, Núm. 1

  6. Minimalist mRNAs: A fast track to cancer vaccines

    Molecular Therapy Nucleic Acids

  7. Phosphatidylserine as a tumor target for CAR-T cell therapy

    Journal for ImmunoTherapy of Cancer, Vol. 13, Núm. 2

  8. Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma

    Blood, Vol. 146, Núm. 24, pp. 2931-2944

  9. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut, Vol. 74, Núm. 2, pp. 270-283

  10. The potential of phytomedicines to optimize CAR-T cell therapy in cancer

    Immunotherapy, Vol. 17, Núm. 13, pp. 953-966

2024

  1. Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope

    Molecular Therapy Nucleic Acids

  2. Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity

    Journal of Neuroinflammation, Vol. 21, Núm. 1

  3. Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  4. Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model

    Journal for immunotherapy of cancer, Vol. 12, Núm. 7